eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2004
vol. 21
 
Share:
Share:
abstract:

How does prednisolone work in pemphigus?

Sergei A. Grando

Post Derm Alerg 2004; XXI, 1: 4–8
Online publish date: 2004/03/15
View full text Get citation
 
In this review the mechanism of action of glucocorticosteroids (GH) in pemphigus is discussed. In pemphigus, GH may work by: (i) inhibiting antibody synthesis; (ii) suppressing inflammation, especially eosinophilic spongiosis; and (iii) stopping acantholysis via a direct pharmacological effect on keratinocytes. The anti-acantholytic effects of methylprednisolone include upregulation of gene expression of adhesion molecules and protection of keratinocyte adhesion molecules from antibody-induced phosphorylation. Experimental drugs, such as lazaroids that are deprived of the mineralocorticoid and glucocorticoid effects of GH, should be tested for their ability to replace GH in the treatment of pemphigus.
keywords:

pemphigus, glucocorticosteroids, keratinocyte

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.